𝔖 Bobbio Scriptorium
✦   LIBER   ✦

De novo design and optimization of Aurora A kinase inhibitors

✍ Scribed by Rodrigues, Tiago; Roudnicky, Filip; Koch, Christian P.; Kudoh, Takayuki; Reker, Daniel; Detmar, Michael; Schneider, Gisbert

Book ID
120258040
Publisher
The Royal Society of Chemistry
Year
2013
Tongue
English
Weight
282 KB
Volume
4
Category
Article
ISSN
2041-6520

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The de novo design and synthesis of cycl
The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand
✍ Robert A. Galemmo Jr.; Brian L. Wells; Karen A. Rossi; Richard S. Alexander; Cel πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 222 KB

In this report refinements to the S4 ligand group leads to compound 19, an inhibitor of fXa with good potency in vitro and an improved pharmacokinetic profile in rabbit. The X-ray crystallographic study of a representative analogue confirms our binding model for this series.

The Pharmacophore Hypothesis of Novel In
The Pharmacophore Hypothesis of Novel Inhibitors for Aurora A Kinase
✍ Xiao-Jian WANG; Ya-Dong CHEN; Qian YANG; Qi-Dong YOU πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 264 KB

## Abstract A three‐dimensional pharmacophore model was developed from a series of inhibitors of Aurora A kinase to discover new potent anti‐cancer agents using the HypoGen module in the Catalyst software. The pharmacophore model was developed based on the structure of 20 currently available inhibi